We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.


Any AUS or NZ company


Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z



Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Click here for free access to this company's:
ASX, Legal & CGT Status


(updated at weekends)

Former (or subsequent) names


Shareholder links

Our website ranking of RD1: rating 3
(3 out of 5)



Registry Direct Limited 10 Exon Street Brighton VIC 3186 PO Box 18366 Collins Street East VIC 8003

Tel : 1300 55 66 35
Fax : +61 3 9111 5652
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000RD14
Address: 10 Exon Street Brighton VIC 3186
Tel:  1300 55 66 35 Fax: +61 3 9111 5652

Date first listed: 01/11/2017
Company Secretary: Ian Steuart Roe
Sector: Software & Services Industry Group: 
Activities: Provider of cloud based shareholder and securities management platform

News & Events

Expand this box to read and print

Letters to eligible and ineligible shareholders for the Entitlement Offer in the Prospectus dated 3 June 2021 have been dispatched.


The company releases an update to its Entitlement Offer Timetable.


The company releases a notice of Proposed issue of Securities.


The company releases a prospectus for a pro-rata non-renounceable entitlement offer of one (1) New Share and for every 1.175273 existing Shares held by Eligible Shareholders on the Record Date, and Shortfall Offer, at an Offer Price of $0.015 to raise approximately $2,200,000 (before costs).


The company launched a fully underwritten $2.2 million Entitlement Offer. Recapitalisation of business exceeds ASX requirements for re-quotation. Underlying business performance is strong, with significant growth in number of paying registries.


The company lodges its Quarterly Activities Report and Appendix 4C.


The company lodges its Appendix 4D and FY21 half year financial report.


Under Listing Rule 17.6, any entity (if not already suspended) that has not paid its annual listing fees by close of business on Friday, 19 February 2021 will have its securities suspended from official quotation before the commencement of trading on Monday, 22 February 2021. The company has not paid the second instalment of its annual listing fees in respect of the year ending 30 June 2021 but the securities are already suspended from official quotation.


The company lodges its Quarterly Report and Appendix 4C.


The insurance claim of $150,000 has been fully paid. The company has suffered no financial loss due to the incident.


The company releases its 2020 Annual General Meeting poll results.


The company releases its Chairman's Address and 2020 AGM presentation.


The company releases a letter to its shareholders regarding its AGM which will be held virtually on 30 November 2020, commencing at 11:00am (Melbourne time).


The company lodges its report on its quarterly activities and Appendix 4C.


The company lodges its FY20 Annual Report.


The company releases its FY20 Appendix 4E.


The company releases its Corporate Governance Statement.


The company releases an Appendix 4G.


Shareholders in this company should consider crystallising a capital loss in 2020/21 by selling their worthless shares, which they can achieve online by entering transaction details here. While this usually makes good economic sense, we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.


The company lodges its Report on Quarterly Activity and Appendix 4C.


The firm's expected research and development claim for the 2019/20 tax year is expected to be approximately $320,000. Registry Direct has entered a financing arrangement with Radium Capital Pty Ltd. Registry Direct has drawn down $180,000 against this facility and does not intend to draw down any addition funds against the R&D claim. Upon receipt of the R&D claim payment by the Australian Tax Office, which is expected in September 2020, the loan will be fully re-paid and the facility closed.


Despite the impacts of the COVID-19 pandemic all client services are and have been uninterrupted and are continuing to operate as normal. If this situation changes, affected parties will be notified. The company has implemented their Business Continuity Plan which has included all staff working from home until further notice. Their office at 2 Russell Street, Melbourne has been closed.


The company lodges its Quarterly activity report and Appendix 4C.


The company lodged its Appendix 4C - March Quarter 2020.


As a result of the material change in market conditions, principally as a result of the COVID-19 pandemic, Complii has advised they are no longer able to raise sufficient funds on the terms previously announced to meet the conditions of the acquisition. As such, they are no longer able to proceed with the acquisition. Registry Direct has terminated the proposed sale of its operating business to Complii.


The company lodges its Appendix 4D and FY20 half year financial report.


The company releases the Chairman's letter to shareholders.


The company has agreed to sell its registry business to Complii FinTech Solutions to create a significant RegTech provider with enhanced scale to deliver innovative solutions within the financial services and securities industry. Under the proposal, RD1 will receive approximately $4.2 million worth of new shares in Complii valuing each RD1 share at approximately 2.4 cents and the combined group will seek to raise up to $5 million in new equity. At completion of the transaction RD1 is expected to own approximately 19.1% of Complii.


The securities of Registry Direct Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of RD1, due to RD1 entering into a proposed transaction involving the sale of its main undertaking under Listing Rule 11.2. RD1 securities will remain suspended until such time it has, subject to shareholder approval, completed the Proposed Transaction, at which time it will be removed from the official list of ASX or should shareholders not approve the Proposed Transaction, it is able to satisfy ASX that it can meet the ongoing requirements expected of a listed entity in Chapter 12 of the Listing Rules.


The rights entitlements (ASX Code: RD1R) to the renounceable issue announced by Registry Direct Limited on 8 June 2018 will be suspended from quotation immediately, following the Company's announcement that the timetable for the Rights Issue will be amended.


listed entity carried for record purposes only

OFX Transferring Money Internationally to Free


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...



    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    19/03/2019Donald McLay37,096$0.040$1,494
    15/03/2019Donald McLay131,729$0.028$3,737
    07/03/2019Donald McLay158,242$0.022$3,488
    06/03/2019Donald McLay672,933$0.022$14,552
    17/04/2018Donald McLay84,326$0.085$7,146

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    Matthew CainChairman01/11/2017
    Steuart RoeManaging Director01/11/2017
    Scott BeetonNon Exec Director03/06/2021

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    Daniel PeadeExecutive Director13/10/202003/06/2021
    Donald McLayNon Exec Chairman01/11/201713/10/2020

    Date of first appointment, title may have changed.